When developing a new drug, there is a whole web of regulations you must navigate in order to get approval from regulatory bodies—such as the U.S. Food and Drug Administration (FDA). Our services focus on bridging the gap between you and these regulatory bodies. The main overarching goals of these services are to oversee the following during the development of a new drug:

Non-Human Clinical Studies

  • Compliance with Regulations
  • Submission of Documentation
  • Clinical Trials
  • Product Labeling and Marketing Approval
  • Post-Market Surveillance

When you partner with us, we will make sure your new drug meets all legal and safety standards throughout the development process.

Our primary expertise lies in the processes outlined above, but if you’re interested in other aspects of CMC Drug Delivery Systems, we’re happy to assess our compatibility with your needs.

Contact Us

MSA News & Insights

What’s going on at Mesa and in the pharmaceutical world at large? Explore this section to find out!

Intern of the Week: Kaitlyn Wylie

Hood College is the educational institution of choice for over 2,000 students in and around Frederick, MD. Many of those…

Read More

Mesa Science Associates and MedSurgPl Join Forces to Offer Convenience and Capability to Startup Biotech Firms

Frederick, MD – Mesa Science Associates, Inc. (MSA) and MedSurgPI, LLC have announced a partnership between their two companies, which…

Read More

Internship Experience Reflection – Kaitlyn Wylie

I never thought my first job would be in the biotechnology and pharmacy industry, let alone with such a passionate…

Read More